The relationship between DNase I-hypersensitive sites (HSs) and transcriptional enhancers of the rat tyrosine aminotransferase (TAT) gene was examined by comparing HSs in and around the TAT gene with the activity of the corresponding DNA sequences in transient transfection assays. In this manner, we identified two HSs as liver-specific enhancers. Of three hepatoma cell lines examined, only one sustained TAT mRNA levels comparable to those of liver. In this cell line, both enhancers were strongly active, and strong hypersensitivity in chromatin over the enhancers was evident. The other two hepatoma cell lines had reduced levels of TAT mRNA and no or altered hypersensitivity over either the enhancers or the promoter. One of these lines carried a negative regulator of the TAT gene, the tissue specific extinguisher Tse-1. This cell line exhibited all HSs characteristic of the strongly active gene except at the promoter; however, one enhancer was inactive even though hypersensitive in chromatin. In a TAT-nonexpressing cell line, inactivity of both enhancers correlated with absence of the respective HSs. We conclude that although hypersensitivity in chromatin necessarily accompanies cell-type-specific enhancer activity, the occurrence of cell-type-specific HSs does not imply that the underlying sequences harbor enhancers active in transient transfection assays.
The association of DNA and protein in the nucleus of eucaryotic cells is referred to as chromatin. The bulk of chromatin is nucleosomal; however, short nucleosomefree regions are detectable by an enhanced rate of cleavage with DNase I and are termed DNase I-hypersensitive sites (DNase I HSs). HSs correlate with regions where cisregulatory elements lie, and it is believed that the hypersensitivity to nucleases reflects accessibility to regulatory proteins (see references 11 and 25 for reviews). Thus, the mapping of HSs surrounding a gene offers a means to locate potential cis-regulatory elements. For example, extensive analysis of chromatin features in the chicken lysozyme gene domain in expressing and nonexpressing tissues and cell lines has elucidated the sequences that control cell-specific and hormone-responsive expression of this gene (summarized in reference 15) .
Recent advances in the understanding of regulated gene expression in higher eucaryotes have highlighted the fact that cis-regulatory elements are frequently located at relatively large distances from the promoter. Studies of the mammalian albumin gene have demonstrated that high-level, tissue-specific expression is a property of the promoter region (20, 30, 38) . However, appropriate expression of albumin gene constructs in transgenic mice requires an element located 10 kilo base pairs (kb) upstream (39) . Similarly, elements located 50 kb 5' to the ,B-globin gene convey position-independent and copy-number-dependent expression in transgenic mice (26) . In both cases, the upstream elements were initially identified as DNase I HSs (13, 39, 48) .
To investigate the control of rat tyrosine aminotransferase (TAT) gene expression, we determined the occurrence of HSs in TAT gene chromatin in expressing and nonexpressing cells and designed transfection experiments based on the location of these sites. The TAT gene is subject to several levels of gene regulation. It is preferentially expressed in parenchymal cells of the adult liver (28) . Gene activity increases dramatically a few hours after birth (24) . TAT transcription can be stimulated by glucocorticoid hormones (23, 42) and by glucagon, which acts via the cyclic AMP (cAMP) pathway (29, 42 ; F. Weih et al., submitted for publication). Both stimuli may be involved in the developmental activation of the gene (40) . In addition, analysis of hepatoma-fibroblast cell hybrids (43) identified a negative regulator of the TAT gene, termed tissue-specific extinguisher 1 (Tse-1; 32). The locus for Tse-J has been mapped to the distal part of human chromosome 17q (34) .
Previously, glucocorticoid-dependent chromatin changes 2.5 kb upstream of the transcription start site (2) led to the definition of the functional glucocorticoid response element of the TAT gene (31 (10 min, 60°C) of the extract was included before the assay to inactivate the deacetylase activity (7). The assay was quantified by liquid scintillation counting of the excised reaction products. The luciferase assay was performed as described elsewhere (9) .
HS mapping. Preparation of nuclei from different glucocorticoid-induced (10-6 M dexamethasone) tissues and cells, DNase I digestions, and indirect end-labeling analyses were performed as described elsewhere (2, 31) .
RNA analyses. RNA preparation and Northern (RNA) analysis were done as described elsewhere (5, 10) . The RNase protection assay was performed as described previously (31) , hybridizing 100 ,ug of total RNA with 10 fmol of a uniformly labeled SP6 transcript (35) . RNA was prepared from cells transfected as described above and harvested after 30 h in serum-free medium. Transfection efficiency was controlled by performing luciferase assays.
RESULTS
Six HSs correlate to high basal level of transcriptional activity. We performed DNase I HS analysis in liver and kidney as well as in three hepatoma cell lines, 7AD-7, 7AE-27, and HTC, and the fibrosarcoma line XC (46) . The basal level of TAT gene expression in these tissues and cell lines was determined by Northern blot analysis (Fig. 1C) . TAT mRNA levels are high in liver and the hepatoma line 7AD-7, low in HTC and 7AE-27 cells, and undetectable in kidney and the fibrosarcoma line XC. 7AD-7 and 7AE-27 are microcell hybrids of a hepatoma line derived from H4IIEC3 that retain part of the long arm of human fibroblast chromosome 17 (33, 34) . Several genetic markers from this chromosomal fragment are present in both 7AD-7 and 7AE-27 cells; however, the Tse-J locus is contained only in 7AE-27 cells. As previously described (32) , the presence of Tse-J resulted in a dramatic reduction of TAT mRNA levels (Fig. 1C , lanes 7AD-7 and 7AE-27). This result is a consequence of reduced transcriptional activity of the gene, as assessed by nuclear run-on experiments (data not shown). We also compared the parental cell line H4IIEC3 and its derivative FTO-2B (32) with 7AD-7 cells and found comparable TAT mRNA levels and identical chromatin structures (data not shown). The hepatoma line HTC (47), which originates from a different tumor do than H4IIEC3-derived cell lines, showed 5-to 10-fold-reduced levels of TAT mRNA compared with liver and 7AD-7 cells (Fig. 1C) .
Chromatin analysis was performed by isolating nuclei from these tissues and cell lines and treating them with increasing amounts of DNase I. Fifteen end-labeling strategies were used to cover the entire gene and up to 20 kb of 5'-and 10 kb of 3'-flanking sequences. The analysis led to the identification of 11 HSs in addition to those reported previously (2) (Fig. 1A and B ). Each HS is named according to its approximate position relative to the transcription start site. These HSs fall into three categories. Two were present in all tissues and cell lines (-18HS and +12HS). Three did not correlate to transcriptional activity or inactivity (-16HS, +4.5HS, and +9HS). The remaining HSs lay between -11 kb and the start site of transcription and showed cell type distributions suggestive of a relationship to the transcriptional activity of the TAT gene. The functional relevance of the glucocorticoid-dependent HS at -2.5 kb has been discussed previously (31) . All cells in this study were treated with glucocorticoids before chromatin analysis to assess whether this site could form. The -2.5HS was the only glucocorticoid-induced chromatin change observable throughout the 40 kb examined. We present the most interesting chromatin features in Fig. 2 to 5.
In Fig. 2 , HSs visible from -16 to -2 kb are compared in kidney, liver, 7AD-7, and XC nuclei. Kidney nuclei showed one prominent HS in this region (-8HS). This HS was not present in any other case examined. Liver and 7AD-7 nuclei displayed the same array of HSs in this region except that liver had an additional HS at -7 kb. XC cells showed only the -16HS (see also Fig. 3 and 4) . Thus, we have identified four HSs (-11HS, -5.4 HS, -4.5HS, and -3.6HS) in addition to the previously identified -1.OHS, -2.5HS, and VOL. 10, 1990 3336 NITSCH ET AL. (C) Northern analysis of 20 ,ug of total RNA isolated from the indicated tissue or cell line. After electrophoresis, the 1.25% agarose gel was blotted and hybridized against an SP6 transcript of pSPcTAT3a (41) . Hybridization against pSP64cGAPDHa (14) was performed to control for RNA loaded (data not shown).
promoter HS, which appear only in liver and a TATexpressing cell line and are therefore candidates as cisregulatory elements.
Differences in chromatin structure of two hepatoma cell lines that express the TAT gene at low levels. From the basal level of TAT mRNA (Fig. 1C) and from the chromatin analysis (Fig. 2) , we conclude that 7AD-7 cells best reflect the status of the TAT gene in liver. Since the levels of TAT mRNA are considerably lower in the hepatoma lines HTC and 7AE-27 and absent in XC cells, we examined TAT gene chromatin in these cells to obtain further indications of the relationship of the above-observed HSs to transcriptional activity. These analyses are presented in Fig. 3 to 5, which show HSs from -7 to +5 kb, from -20 to -10 kb, and from -3 to +1 kb, respectively.
In HTC nuclei, only four (-11HS, -5.4HS, -2.5HS, and promoter HS) of the seven HSs present in 7AD-7 nuclei between -11 kb and the promoter were apparent. Furthermore, the -11HS had a different substructure in HTC than in 7AD-7 cells (Fig. 4) . In contrast, 7AE-27 nuclei displayed an HS pattern identical to that of the Tse-l-negative line, 7AD-7, except for the promoter HS ( Fig. 3 and 5 ). Analysis from a nearby restriction site revealed that the promoter HS in 7AE-27 cells was not completely absent as appears in Fig.  3 , but the typical doublet seen in liver, 7AD-7, and HTC cells was reduced to the proximal cleavage ( Fig. 5 and data (Fig. 1A) . HSs are indicated by arrows on the right. Artifactual bands are marked by asterisks (compare with Fig. 3 and 4) .
plasmids with deletion endpoints from -18.7 to -4.3 kb. Further deletion to -3.0 kb, however, led to a >50-fold drop in CAT activity. The additionally deleted sequences harbor the -3.6HS. The 5' deletion series was also transfected into HTC and 7AE-27 cells. Consistent with the reduced endogenous TAT mRNA levels in these two cell lines (Fig. 1C) Fig. 3 was cut with ApaI, electrophoresed in a 1% agarose gel, blotted, and indirectly end labeled to the ApaI site at -8591 in the TAT upstream region, using a T3 RNA polymerase transcript of subclone XA600 (Fig. 1A) . Lane C, Protein-free DNA digested with DNase I (50 U/ml). HSs are indicated by arrows on the right. much lower levels of CAT activity were observed, and deleting the -3.6HS had no effect (Fig. 6A) . However, in 7AE-27 cells, deletion of sequences between -11 and -9 kb led to a >10-fold drop in activity (compare pTC11.1 with pTC9.2). A weaker effect (two-to threefold) with the same constructs was also observed in HTC cells.
To verify the results of the 5' deletion series, plasmids with internal deletions were transfected to look for loss of expression compared with the parental plasmid (Fig. 6B) . with ScaI, electrophoresed in a 0.6% agarose gel, blotted, and indirectly end labeled to the ScaI site at -9383 in the TAT upstream region, using a T3 RNA polymerase transcript of subclone XA600 (Fig. 1A) . Lane C, Protein-free DNA digested with DNase I (50 U/ml). HSs are indicated by arrows on the right. P, Promoter HS. and 7AE-27 cells. Nuclei of glucocorticoid-induced 7AD-7 and 7AE-27 cells were digested with increasing amounts of DNase I as indicated. A 20-jig sample of purified DNA was cut with HindIII, electrophoresed on a 1.25% agarose gel, blotted, and indirectly end labeled to the HindIII site at +1500 in the TAT-coding sequences, using a T7 transcript of subclone SH800 (Fig. 1A) Fig. 6B ).
The results with the 5' and internal deletion constructs showed that there is a critical positive regulatory region 3.6 kb upstream of the transcription start site, which is strongly active in 7AD-7 cells but not in cell lines HTC and 7AE-27. Additional stimulatory sequences reside in a region that coincides with the -11HS, but in 7AD-7 cells this is obscured by the strong activity correlating with the more proximal -3.6HS. The effect of the distal element could be clearly documented in 7AD-7 cells if the proximal -3.6HS was deleted (compare pTC11.1A-3.6HS with pTC9.2A -3.6HS in Fig. 6B ). Figure 7 shows results of transfecting plasmids that position individual DNase I HSs in direct proximity to the TAT promoter. These constructs are designated pTC-11HS, pTC-5.4HS, and pTC-3.6HS. Comparison of these plasmids in 7AD-7, HTC, 7AE-27, and XC cells conclusively assigns enhancing activity to the sequences containing the HSs at -3.6 and -11 kb. The construct containing the -5.4HS and -4.5HS (pTC-5.4HS), on the other hand, showed no effect. The -3.6 region exerted its 50-fold stimulation only in 7AD-7 cells, weakly in 7AE-27 cells, and not at all in the hepatoma line HTC, as was apparent from the results obtained with the 5' deletion mutants. The -11HS, when placed near the promoter, enhanced TAT transcription in 7AD-7 and 7AE-27 cells several hundredfold and 5-to 10-fold in HTC cells. Both constructs failed to stimulate CAT activity in XC cells, demonstrating cell type specificity of these two elements. Subsequently, we have been able to confine the sequences responsible for transcriptional enhancement entirely to regions within the HSs, and constructs containing these HSs in the reverse orientation produce the same results (data not shown).
Constructs which similarly position the -18HS, -16HS, and -7HS in front of the TAT promoter failed to reveal any role for these regions in transcriptional regulation in hepatoma and fibroblast cell lines when tested in transient trans- fections (data not shown). This is also the case with the hepatocyte-specific HS at -1.0 kb. The presence of this site, for which in vivo protein binding has been documented (3), does not influence the activity of CAT fusion constructs (compare pTCO.35 and 3.0 in Fig. 6A ). Internal deletion of this HS also does not change any property measurable in transient transfections (data not shown). At present, we cannot rule out the possibility that some of the abovementioned HSs must be integrated to convey regulatory function. Also, HSs at the extreme upstream positions (-18HS and -16HS) could mark features of a neighboring locus of other cell type specificity.
To confirm that the effects measured as CAT activity reflect correct transcriptional regulation at the TAT promoter, RNase protection experiments were performed on RNAs isolated from 7AD-7 cells. Maximal activity of the pTC18.7 construct was lost in two steps (Fig. 8) : first, upon deletion of the -11HS (compare pTC11.1 and pTC9.2), and second, upon deletion of the -3.6HS (pTC4.3 versus pTC3.0). The activating potential of the distal element compared with that of the proximal element is documented by constructs which position the respective sequences in front of the TAT promoter (pTC-11HS and pTC-3.6HS; compare Fig. 7) . In all cases, the correct start site has been used; furthermore, the results qualitatively reflect the effects seen in the CAT assays.
DISCUSSION
Chromatin and transcriptional control elements of the TAT gene. We have analyzed 40 kb of chromatin around the rat TAT gene in different tissues and cell lines for DNase I HSs. HSs at the extreme 5'-and 3'-flanking sequences (-18HS and + 12HS) appear in all analyzed nuclei. Some HSs (-16HS, +4.5HS, and +9HS) do not correspond to transcriptional activity or inactivity. On the other hand, a complex array of HSs located between the transcription start site and 11 kb upstream (-11HS, -5.4HS, -4.5HS, -3.6HS, -2.5HS, -1.OHS, and promoter HS) is observed in liver and the TAT-expressing hepatoma line 7AD-7. Interestingly, only three of these HSs (-5.4HS, -2.5HS, and promoter HS) are fully established in the hepatoma line HTC, which expresses 5-to 10-fold less TAT mRNA than do 7AD-7 cells. In contrast, 7AE-27, a cell line which shows even lower basal TAT mRNA levels (Fig. 1C) because of the presence of the human Tse-J locus (34), differs from 7AD-7 cells in DNase I HS pattern only in reduced hypersensitivity at the promoter.
Transient transfection experiments have defined two regions that stimulate TAT transcription, in addition to the glucocorticoid responsive enhancer at -2.5 kb previously described (31) . These two enhancers lie far upstream of the promoter and coincide with the -3.6HS and -11HS. Both elements act in a hepatoma-specific manner; however, the activity of the -3.6 enhancer is restricted to the H4IIEC3-derived cell line 7AD-7. It is not active in HTC cells, which do not show the corresponding HS. The -3.6 enhancer also contains a cAMP response element of the TAT gene, which not only mediates cAMP responsiveness but also functions to raise the basal level of TAT transcription (Weih et al., submitted). We conclude that in HTC cells, the lower basal level of TAT transcription as well as the absence of a transcriptional response to cAMP alone (22) is in part due to the inactivity of the enhancer that creates this HS. In 7AE-27 cells the -3.6 enhancer activity is greatly reduced, but the corresponding HS is as strong as that which lies over the active enhancer in 7AD-7 cells. A detailed analysis of this enhancer and the basis of its inactivity in 7AE-27 cells will be presented elsewhere (M. Boshart, F. Weih, A. Schmidt, R. E. K. Fournier, and G. Schutz, Cell, in press).
The TAT gene has a second far upstream enhancer (-11HS) whose activity in CAT assays is obscured by the strong effect of the more proximal -3.6HS when both elements are active. Constructs which juxtapose the respective sequences to the TAT promoter establish that the upstream enhancer is the stronger of the two ( Fig. 7 and 8 ). Possibly transient transfection experiments are inadequate to describe fully the in vivo function of the distal element. In the a-fetoprotein gene, three enhancers, located 2.5, 5.0, and 6.5 kb upstream, were shown to be functionally equivalent and nonadditive in transient transfections (16, 17) . Transgenic mice and chromatin analysis, however, defined variations between tissues in the utilization of the three enhancers (18, 27 Although the promoters of many other liver genes strongly stimulate transcriptional activity (6, 8, 16, 17, 20, 30, 37) , we observed that the TAT promoter is relatively weak in the absence of its upstream elements. Nevertheless, the observation that the presence of Tse-J alters the promoter-HS (Fig. 5) In another hepatoma cell line, HTC, the -11 enhancer activity and corresponding HS are weaker than in 7AD-7 cells. The -3.6 enhancer activity and HS are absent. The reduced activity of these two enhancers correlates to lower levels of endogenous TAT mRNA. The promoter-HS is strong, and the transcriptional activity of the gene can be stimulated by glucocorticoids through the inducible enhancer and HS at -2.5 kb.
In the Tse-J-containing cell line 7AE-27, the -11 enhancer activity and HS are both strong. Although the -3.6 enhancer is almost completely inactive, its corresponding HS is fully established. By comparison with HTC cells, it can be seen that both of these enhancers are more active in 7AE-27 cells, although TAT mRNA levels are lower (Table 1 ). This incongruency suggests that the promoter has functional relevance, since in 7AE-27 cells, hypersensitivity is altered only at the promoter. The reduced promoter HS may be a result of direct action by Tse-1. Alternatively, it may be a consequence of Tse-l-induced alterations of the -3.6 enhancer. The following observation might also indicate a role of promoter sequences in TAT gene control in 7AE-27 cells. In transient transfection experiments, the -2.5 enhancer responds to glucocorticoids. However, transcriptional stimulation of the endogenous gene is impaired, even though the HS is inducible (32; data not shown). Experiments to establish whether Tse-1 exerts an effect on the TAT gene in HTC cells, in which the -3.6HS is not present, would resolve this issue.
In XC cells, both the -11 and -3.6 enhancers are inactive and the corresponding HSs are absent. The -2.5HS is not inducible with glucocorticoids, but the corresponding enhancer activity is partially inducible. This finding indicates the presence of the glucocorticoid receptor in XC cells and its ability to activate the -2.5 enhancer when the latter is transfected but not in chromatin. So far, no function for this DNase I HS has been found. Furthermore, although we observe a correlation between enhancer activity and the structure of the -11HS, we also find, with the -3.6HS, a situation where hypersensitivity over an enhancer does not correlate to the activity of the enhancer. These findings lead us to draw the following unidirectional conclusion. cis elements that regulate celltype-specific gene transcription lie within DNase I HSs. However, the occurrence of a cell-type-specific DNase I HS does not imply the existence of cis-regulatory elements active in transient transfection assays.
